Maravai Lifesciences Holdings (MRVI) Income from Non-Controlling Interests (2020 - 2026)

Maravai Lifesciences Holdings' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2026.

• In Q1 2026, Income from Non-Controlling Interests rose 88.46% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$79.7 million (up 37.26% YoY), while the FY2025 annual figure was -$100.0 million, up 12.88% from the prior year.
• Income from Non-Controlling Interests for Q1 2026 stood at -$2.6 million, up from -$27.3 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $85.5 million in Q2 2022, with the low at -$75.4 million in Q3 2024.
• The 5-year median for Income from Non-Controlling Interests is -$8.6 million (2024), against an average of $2.0 million.
• The sharpest annual moves came in 2024 and 2026: Income from Non-Controlling Interests slumped 772.47% in 2024, then jumped 88.46% in 2026.
• Maravai Lifesciences Holdings' Income from Non-Controlling Interests stood at $49.8 million in 2022, then plunged by 108.08% to -$4.0 million in 2023, then tumbled by 401.17% to -$20.2 million in 2024, then plunged by 35.57% to -$27.3 million in 2025, then surged by 90.33% to -$2.6 million in 2026.
• Business Quant data shows MRVI's Income from Non-Controlling Interests at -$2.6 million in Q1 2026, -$27.3 million in Q4 2025, and -$19.5 million in Q3 2025.